Journal of Cancer Research and Therapeutics Close
 

Figure 1: (a-b) CT with contrast after 4 weeks of imatinib showing tumors in left upper quadrant, and segments 8 and 6 of the liver. (c-d) CT with contrast after 23 months of imatinib treatment showing septal-like enhancement in the mass on segment 8 and a new enhancing nodule in the mass on segment 6 of the liver

Figure 1: (a-b) CT with contrast after 4 weeks of imatinib showing tumors in left upper quadrant, and segments 8 and 6 of the liver. (c-d) CT with contrast after 23 months of imatinib treatment showing septal-like enhancement in the mass on segment 8 and a new enhancing nodule in the mass on segment 6 of the liver